Abstracts
BACKGROUND:
Knowing the potential for and limitations of information generated using different evaluation instruments favors the development of more accurate functional diagnoses and therapeutic decision-making.
OBJECTIVE:
To investigate the relationship between the number of compensatory movements when climbing up and going down stairs, age, functional classification and time taken to perform a tested activity (TA) of going up and down stairs in boys with Duchenne muscular dystrophy (DMD).
METHOD:
A bank of movies featuring 30 boys with DMD performing functional activities was evaluated. Compensatory movements were assessed using the climbing up and going down stairs domain of the Functional Evaluation Scale for Duchenne Muscular Dystrophy (FES-DMD); age in years; functional classification using the Vignos Scale (VS), and TA using a timer. Statistical analyses were performed using the Spearman correlation test.
RESULTS:
There is a moderate relationship between the climbing up stairs domain of the FES-DMD and age (r=0.53, p=0.004) and strong relationships with VS (r=0.72, p=0.001) and TA for this task (r=0.83, p<0.001). There were weak relationships between the going down stairs domain of the FES-DMD-going down stairs with age (r=0.40, p=0.032), VS (r=0.65, p=0.002) and TA for this task (r=0.40, p=0.034).
CONCLUSION:
These findings indicate that the evaluation of compensatory movements used when climbing up stairs can provide more relevant information about the evolution of the disease, although the activity of going down stairs should be investigated, with the aim of enriching guidance and strengthening accident prevention. Data from the FES-DMD, age, VS and TA can be used in a complementary way to formulate functional diagnoses. Longitudinal studies and with broader age groups may supplement this information.
CONTEXTUALIZAÇÃO:
Conhecer as potencialidades e limitações das informações geradas por diferentes instrumentos de avaliação favorece o desenvolvimento mais preciso do diagnóstico funcional e da tomada de decisão terapêutica.
OBJETIVO
: Investigar a relação entre o número de movimentos compensatórios ao subir e descer escadas, idade, classificação funcional e tempo de realização de atividade (TA) em meninos com Distrofia Muscular de Duchenne (DMD).
MÉTODO
: Foi utilizado banco de filmes de 30 meninos com DMD realizando atividades funcionais. Os movimentos compensatórios foram avaliados pela Escala de Avaliação Funcional para Distrofia Muscular de Duchenne (FES-DMD), domínio subir e descer escada; a idade, mensurada em anos; a classificação funcional foi pesquisada pela Escala de Vignos (EV), e o TA foi cronometrado. Foi utilizado o teste de correlação de Spearman.
RESULTADOS
: Existe moderada relação entre a FES-DMD-subir escada e a idade (r=0,53, p=0,004) e forte relação com a EV (r=0,72, p=0,001) e TA dessa tarefa (r=0,83, p<0,001). Houve fraca relação entre a FES-DMD-descer escada e a idade (r=0,40, p=0,032), EV (r=0,65, p=0,002) e o TA dessa tarefa (r=0,40, p=0,034).
CONCLUSÃO
: Esses achados indicam que a avaliação da tarefa de subir escada pode trazer informações mais relevantes sobre a evolução da doença, embora a atividade de descer escada deva ser pesquisada visando à orientação e prevenção de acidentes. A utilização conjunta de dados provenientes da FES-DMD, da idade e do TA pode se complementar para formulação do diagnóstico funcional. Estudos longitudinais e com outras faixas etárias mais amplas podem complementar tal informação.
Introduction
Duchenne muscular dystrophy (DMD) is a genetic disease caused by the alteration of gene
Xp21, which encodes the protein dystrophin. DMD affects one in every 3,500 male live
births11. McDonald CM. Physical activity, health impairments, and disability in
neuromuscular disease. Am J Phys Med Rehabil. 2002;81(11, Suppl):S108-20.
http://dx.doi.org/10.1097/00002060-200211001-00012. PMid:12409816
https://doi.org/10.1097/00002060-2002110...
. From the clinical point of view, DMD
is characterized by progressive, generalized and irreversible muscle weakness, which
progresses distally, bilaterally, symmetrically and in an ascending direction. The
disease progression is associated with loss of motor skills, mainly in the lower limbs
with patients losing their ambulation capacity by age nine to 13 years old. Affected
individuals require non-invasive mechanical ventilation from the second decade of life
onwards, and death is often due to cardiorespiratory complications22. Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J. The
multidisciplinary management of Duchenne muscular Dystrophy. Curr Paediatr.
2005;15(4):292-300. http://dx.doi.org/10.1016/j.cupe.2005.04.001.
https://doi.org/10.1016/j.cupe.2005.04.0...
3. Ambrosino N, Carpenè N, Gherardi M. Chronic respiratory care for
neuromuscular diseases in adults. Eur Respir J. 2009;34(2):444-51.
http://dx.doi.org/10.1183/09031936.00182208. PMid:19648521
https://doi.org/10.1183/09031936.0018220...
-
44. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et
al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation
of multidisciplinary care. Lancet Neurol. 2010;9(2):177-89.
http://dx.doi.org/10.1016/S1474-4422(09)70272-8. PMid:19945914
https://doi.org/10.1016/S1474-4422(09)70...
.
The decline of the motor activities over the course of the disease is unavoidable. The
use of functional assessment scales is needed for clinical follow-up, establishment of
the functional diagnosis, and therapeutic decision-making55. Zanoteli E. Predicting the loss of ambulation in Duchenne muscular
dystrophy. Arq Neuropsiquiatr. 2014;72(1):1-2.
http://dx.doi.org/10.1590/0004-282X20130243. PMid:24637971
https://doi.org/10.1590/0004-282X2013024...
6. Silva EC, Machado DL, Resende MB, Silva RF, Zanoteli E, Reed UC.
Motor function measure scale, steroid therapy and patients with Duchenne muscular
dystrophy. Arq Neuropsiquiatr. 2012;70(3):191-5. PMid:22392111.
-
77. Scott E, Mawson SJ. Measurement in Duchenne muscular dystrophy:
considerations in the development of a neuromuscular assessment tool. Dev Med Child
Neurol. 2006;48(6):540-4. http://dx.doi.org/10.1017/S0012162206001137.
PMid:16700951
https://doi.org/10.1017/S001216220600113...
.
There are several functional scales specific for the assessment of individuals with
neuromuscular diseases. The Vignos scale (VS)88. Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive
muscular dystrophy in childhood. JAMA. 1963;184:89-96.
http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
https://doi.org/10.1001/jama.1963.037001...
allows staging of the disease and focuses on functional activities mainly involving the
lower limbs, which are considered milestones in the progression of disease. In VS,
function is scored from 0 to 10, with higher scores representing poorer functional
performance. This classic scale was the basis for the formulation of other scales that
aimed at performing a more detailed assessment of the functional capacity of individuals
with neuromuscular diseases, such as the Motor Function Measure Scale99. Bérard C, Payan C, Hodgkinson I, Fermanian J, MFM Collaborative Study
Group. A motor function measure for neuromuscular diseases. Construction and
validation study. Neuromuscul Disord. 2005;15(7):463-70.
http://dx.doi.org/10.1016/j.nmd.2005.03.004. PMid:16106528
https://doi.org/10.1016/j.nmd.2005.03.00...
(MFM). The MFM assesses functional activities in
three dimensions, such as standing and transfers, axial and proximal motor function, and
distal motor function, and establishes whether the subject partially completes the
exercise, completes it with compensatory movements, or does not perform it at all. The
MFM showed good responsiveness, especially in patients with DMD, and was in agreement
with the patients' and physicians' perceived changes1010. Vuillerot C, Payan C, Girardot F, Fermanian J, Iwaz J, Bérard C, et
al. Responsiveness of the motor function measure in neuromuscular diseases. Arch Phys
Med Rehabil. 2012;93(12):2251-6.e1. http://dx.doi.org/10.1016/j.apmr.2012.05.025.
PMid:22705238
https://doi.org/10.1016/j.apmr.2012.05.0...
. The MFM-short form, for use in children aged two to seven years old,
showed satisfactory intra- and interexaminer reliability1111. de Lattre C, Payan C, Vuillerot C, Rippert P, de Castro D, Bérard C,
et al. Motor function measure: validation of a short form for young children with
neuromuscular diseases. Arch Phys Med Rehabil. 2013;94(11):2218-26.
http://dx.doi.org/10.1016/j.apmr.2013.04.001. PMid:23602884
https://doi.org/10.1016/j.apmr.2013.04.0...
.
On the North Star Ambulatory Assessment scale1212. Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, et al.
Development of a functional assessment scale for ambulatory boys with Duchenne
muscular dystrophy. Physiother Res Int. 2012;17(2):101-9.
http://dx.doi.org/10.1002/pri.520. PMid:21954141
https://doi.org/10.1002/pri.520...
,
activities are graded 0 to 3, depending on whether subjects do or do not perform the
activities and whether they perform them in an adapted manner. Formulated for ambulant
children with DMD, according to Mazzone et al.1313. Mazzone E, Martinelli D, Berardinelli A, Messina S, D'Amico A, Vasco
G, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in
ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord.
2010;20(11):712-6. http://dx.doi.org/10.1016/j.nmd.2010.06.014.
PMid:20634072
https://doi.org/10.1016/j.nmd.2010.06.01...
,
this scale should be used in combination with outcome measures, such as the six-minute
walk test, to provide information on different aspects of motor function that may not be
captured using a single measure.
The abovementioned scales provide descriptions of compensatory strategies in the
performance of tasks but do not afford kinesiological details relative to compensatory
movements involving the trunk, pelvis, knees, ankles and feet. They also do not provide
detailed information on the movements involved in climbing up or going down stairs,
which, according to Vignos, are two of the activities of daily life that should be
investigated88. Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive
muscular dystrophy in childhood. JAMA. 1963;184:89-96.
http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
https://doi.org/10.1001/jama.1963.037001...
. One further assessment
frequently applied to individuals with DMD is the measurement of time spent in the
performance of functional activities, such as climbing up stairs, standing from a seat
and walking. Generally, the use of compensatory movements tends to increase the time
spent in the performance of the activities tested and thus is indicative of worsening of
the functional status55. Zanoteli E. Predicting the loss of ambulation in Duchenne muscular
dystrophy. Arq Neuropsiquiatr. 2014;72(1):1-2.
http://dx.doi.org/10.1590/0004-282X20130243. PMid:24637971
https://doi.org/10.1590/0004-282X2013024...
6. Silva EC, Machado DL, Resende MB, Silva RF, Zanoteli E, Reed UC.
Motor function measure scale, steroid therapy and patients with Duchenne muscular
dystrophy. Arq Neuropsiquiatr. 2012;70(3):191-5. PMid:22392111.
7. Scott E, Mawson SJ. Measurement in Duchenne muscular dystrophy:
considerations in the development of a neuromuscular assessment tool. Dev Med Child
Neurol. 2006;48(6):540-4. http://dx.doi.org/10.1017/S0012162206001137.
PMid:16700951
https://doi.org/10.1017/S001216220600113...
8. Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive
muscular dystrophy in childhood. JAMA. 1963;184:89-96.
http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
https://doi.org/10.1001/jama.1963.037001...
9. Bérard C, Payan C, Hodgkinson I, Fermanian J, MFM Collaborative Study
Group. A motor function measure for neuromuscular diseases. Construction and
validation study. Neuromuscul Disord. 2005;15(7):463-70.
http://dx.doi.org/10.1016/j.nmd.2005.03.004. PMid:16106528
https://doi.org/10.1016/j.nmd.2005.03.00...
10. Vuillerot C, Payan C, Girardot F, Fermanian J, Iwaz J, Bérard C, et
al. Responsiveness of the motor function measure in neuromuscular diseases. Arch Phys
Med Rehabil. 2012;93(12):2251-6.e1. http://dx.doi.org/10.1016/j.apmr.2012.05.025.
PMid:22705238
https://doi.org/10.1016/j.apmr.2012.05.0...
11. de Lattre C, Payan C, Vuillerot C, Rippert P, de Castro D, Bérard C,
et al. Motor function measure: validation of a short form for young children with
neuromuscular diseases. Arch Phys Med Rehabil. 2013;94(11):2218-26.
http://dx.doi.org/10.1016/j.apmr.2013.04.001. PMid:23602884
https://doi.org/10.1016/j.apmr.2013.04.0...
-
1212. Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, et al.
Development of a functional assessment scale for ambulatory boys with Duchenne
muscular dystrophy. Physiother Res Int. 2012;17(2):101-9.
http://dx.doi.org/10.1002/pri.520. PMid:21954141
https://doi.org/10.1002/pri.520...
.
Observation of functional activities is a simple and accessible ay to assess patients in
clinical practice. In addition, such observational tests may be filmed, thus providing a
permanent record. Systematized observational analysis is a focus of interest of the
authors of the present study, who formulated a specific scale for this purpose: the
Functional Evaluation Scale for DMD (FES-DMD). This scale aims at elucidating the
potentialities and limitations of the information afforded by systematized observation
of functional activities and thus contributes to improving the precision of functional
diagnoses and therapeutic decision-making1414. Fernandes LA, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV.
Elaboration and reliability of functional evaluation on going up and downstairs scale
for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26.
http://dx.doi.org/10.1590/S1413-35552010000600011. PMid:21340247
https://doi.org/10.1590/S1413-3555201000...
.
The FES-DMD climbing up and going down stairs domain was formulated to allow for
specific evaluation of these activities based on systematized observation by means of
filming, thus allowing for descriptive analyses of the movements involved, including the
compensatory ones, generation of numerical scores, and calculation of the time spent in
the performance of the tested activity (TA). The intra- and interexaminer reliability of
the FES-DMD has been demonstrated in a previous study1414. Fernandes LA, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV.
Elaboration and reliability of functional evaluation on going up and downstairs scale
for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26.
http://dx.doi.org/10.1590/S1413-35552010000600011. PMid:21340247
https://doi.org/10.1590/S1413-3555201000...
.
The TA variable and the VS score are frequently used to classify the functional status
of patients. The patients' age also provides an approximation of the clinical
progression status1515. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J,
et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of
supportive therapy. Neurology. 1989;39(4):475-81.
http://dx.doi.org/10.1212/WNL.39.4.475. PMid:2927672
https://doi.org/10.1212/WNL.39.4.475...
. However, few studies have
sought to correlate these variables with the presence of compensatory movements in the
performance of functional activities1414. Fernandes LA, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV.
Elaboration and reliability of functional evaluation on going up and downstairs scale
for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26.
http://dx.doi.org/10.1590/S1413-35552010000600011. PMid:21340247
https://doi.org/10.1590/S1413-3555201000...
,
1818. Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, et al. The
correlation analysis of functional factors and age with duchenne muscular dystrophy.
Ann Rehabil Med. 2012;36(1):22-32. http://dx.doi.org/10.5535/arm.2012.36.1.22.
PMid:22506232
https://doi.org/10.5535/arm.2012.36.1.22...
, and the contribution of each needs to be
understood.
Jung et al.
1818. Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, et al. The
correlation analysis of functional factors and age with duchenne muscular dystrophy.
Ann Rehabil Med. 2012;36(1):22-32. http://dx.doi.org/10.5535/arm.2012.36.1.22.
PMid:22506232
https://doi.org/10.5535/arm.2012.36.1.22...
assessed the correlation between existing
evaluation tools and clinical information on DMD patients, i.e. the Brooke scale, VS,
bilateral shoulder abductor and knee extensor muscle power, passive ranges of motion
(PROM) of ankle dorsiflexion, angle of scoliosis, peak cough flow (PCF), age, functional
muscular shortening (FS), genetic abnormalities and the use of steroids). The results
revealed that the scores in the Brooke and Vignos scales increased linearly with age,
while the PROM of ankle dorsiflexion exhibited a linear decrease. The muscle power, Cobb
angle, PCF and FS varied in their degrees, irrespective of age. Statistically, the
genetic abnormalities and use of steroids were not associated with the scores on the
functional scales. These findings clearly showed that age should not be used alone.
We believe that the existing scales contribute to the stock of assessment parameters, although it is clear that evaluation routines should be established to monitor the development of each child, adolescent or adult with DMD on an individual basis. Tests and exams that are able to elucidate specific clinical and functional intercurrent events should be used in association at each stage of disease progression.
The objective of this study was to investigate the possible relationships between the number of compensatory movements during climbing up and going down stairs, the functional classification, patients' age and the time required to perform these two tasks in children with DMD.
Method
Participants
This study used a film library of 30 children diagnosed with DMD, mean age 7.1 years old (SD: 2.2), mean body weight 40.8 Kg (SD:10.4) and mean height 1.39 m (SD:0.17), made available by Laboratory of Myopathies, Institute of Biosciences, Universidade de São Paulo (USP), São Paulo, SP, Brazil. In the films, the children were performing several functional tasks according to a pre-established script and standardization. The films were made after the children gave informed voluntary consent and their legal guardians signed an informed consent form.
The films included in this study represented children with diagnoses of DMD confirmed by means of DNA testing who were able to climb up and go down stairs without assistance from another person. Further inclusion criteria were as follows: involved in physical therapy at least once per week and using corticoids for at least one year. The films of children requiring lower limb orthoses to perform the investigated tasks were excluded.
The study was conducted at the Laboratory of Physical Therapy and Behavior, Course of Physical Therapy, Faculdade de Medicina (FM), USP, following approval by the research ethics committee of FM/USP (837/05).
Equipment
The films were recorded with a digital video camera (Digital Camcorder Full HD Sony HDR-CX220 8.9 MP 32x optical zoom) placed on a 1-meter-tall tripod, 3 meters away from and perpendicular to the stairs. The children were filmed in the sagittal plane while performing the indicated tasks, as recommended by FES-DMD. The stairs had six steps to climb up (10 x 27 x 30 cm), four steps to climb down (17 x 25 x 30 cm), being the measure of height, depth and width of each step, respectively, and bilateral standard handrails. Filming started when the investigator gave a verbal command to the child to perform the task as fast as he could.
Procedure
Instruments, measurement and data collection
Assessment of functional activity while climbing up and going down stairs was
performed using the FES-DMD, a functional scale specific for the functional
assessment of children with DMD. This scale assesses activities such as standing from
and sitting on a chair and on the ground, climbing up and going down stairs, and
walking. The FES-DMD records and describes the movements performed by subjects, with
particular focus on compensatory movements. The FES-DMD - climbing up stairs
assessment is divided into five phases: preparation/standing, propulsion, swinging,
lower limb swinging and stance. The going down stairs assessment is divided into four
phases: preparation/standing, propulsion, swinging and stance. In the FES-DMD domain
climbing up and going down stairs, the lower the final score, the lower the number of
compensatory movements and the better the subject's performance in that activity1414. Fernandes LA, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV.
Elaboration and reliability of functional evaluation on going up and downstairs scale
for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26.
http://dx.doi.org/10.1590/S1413-35552010000600011. PMid:21340247
https://doi.org/10.1590/S1413-3555201000...
,
1616. Escorcio R, Caromano FA, Hukuda ME, Fernandes LA. Development of an
evaluation scale for sitting and standing from the ground for children with Duchenne
muscular dystrophy. J Mot Behav. 2011;43(1):31-6.
http://dx.doi.org/10.1080/00222895.2010.530306. PMid:21186460
https://doi.org/10.1080/00222895.2010.53...
,
1818. Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, et al. The
correlation analysis of functional factors and age with duchenne muscular dystrophy.
Ann Rehabil Med. 2012;36(1):22-32. http://dx.doi.org/10.5535/arm.2012.36.1.22.
PMid:22506232
https://doi.org/10.5535/arm.2012.36.1.22...
. The indicated task consisted of climbing
up six steps and going down four steps to come back to ground level. Prior to
filming, the children were requested to sit for five minutes before the performance
of the indicated functional tasks so that fatigue would not to impair their
performance. Next, the activities of the FES-DMD were requested. The use of aids was
allowed.
The films were analyzed by a physical therapist with at least five years of clinical experience in neuropediatrics who was previously trained in the use of the FES-DMD and who was blinded to the study objectives.
To measure the TA, the children were requested to climb the up and go down the stairs
as fast as they could. The time elapsed from the moment the investigator gave the
verbal command to start to the moment the child's two feet contacted the last stair
step was measured. The VS scores and age were extracted from the children's clinical
records. VS consisted of 10 functional items with decreasing level of difficulty; the
higher the score, the poorer the subject's motor performance88. Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive
muscular dystrophy in childhood. JAMA. 1963;184:89-96.
http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
https://doi.org/10.1001/jama.1963.037001...
.
Data analysis
The statistical analysis of the data was performed using the software Statistica 11.0 (Statsoft SOUTH AMERICA, 2013). Spearman's correlation test was used to investigate possible associations between FES-DMD-climbing up and going down stairs domain, VS, TA and age. The participants' ages were collected in months and then converted to years through cross-multiplication. The significance level was established as p<0.05.
Results
The mean score on the FES-DMD-climbing up stairs was 16.7 (SD=8.4), and the mean score on the FES-DMD-going down stairs was 16.0 (SD=8.6). The mean classification score on the VS was 3.1 (SD=1.1). The TA for climbing up the stairs was 11.3 seconds (SD=10.7), and the mean TA for going down the stairs was 11.1 seconds (SD=13.5).
Spearman's correlation test revealed a moderate correlation between the FES-DMD scores for climbing up the stairs and age (r=0.53; p=0.004) and a weak correlation between the FES-DMD scores for going down the stairs and age (Figure 1). The older the subjects' ages, the higher the scores in the FES-DMD-climbing up and going down the stairs (r=0.40; p=0.032).
Additionally, the VS classification score exhibited correlations with FES-DMD-climbing up and going down the stairs (r=0.72; p<0.001 and r=0.56; p=0.002, respectively) (Figure 2). The worse the functional classification on VS, the higher the number of compensatory movements detected by the FES-DMD on both tasks investigated.
The FES-DMD-climbing up the stairs was strongly correlated with the TA (r=0.83; p<0.001) (Figure 3), while the correlation between the FES-DMD-going down the stairs and TA was weak (r=0.40; p<0.034) (Figure 3). For both tasks investigated, the higher the TA, the higher the FES-DMD scores, thus indicating a larger number of compensatory movements.
Discussion
This study investigated the possible relationships between FES-DMD-climbing up and going down the stairs scores with the patients' age and VS classification. In addition, it also investigated the possible relationship of the time taken to do the movement with the activities.
The correlation between the scores on FES-DMD-climbing up and going down the stairs and
the subjects' age was moderate to weak. As expected, the older the children's age, the
poorer their performance. In a study conducted with 121 children with DMD (mean age=9.9
years old, SD=3.4), Young Jung et al.1818. Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, et al. The
correlation analysis of functional factors and age with duchenne muscular dystrophy.
Ann Rehabil Med. 2012;36(1):22-32. http://dx.doi.org/10.5535/arm.2012.36.1.22.
PMid:22506232
https://doi.org/10.5535/arm.2012.36.1.22...
found a
correlation between the scores on the Brooke and Vignos scales and age. Different from
broad-scoped scales, which investigate several tasks as a rule, in the present study,
only two highly specific tasks were assessed. For this reason, our results complement
the findings reported by those authors.
While individuals with DMD suffer functional losses over time, the wide variability characteristic of the clinical disease progression may make the prognosis difficult to predict, especially when only age is used as the base. Nevertheless, understanding the relationship between age and the clinical course is crucial for understanding the disease progression over time, especially when considering that it may vary widely among the affected individuals.
The main goal of any interventions currently available is to delay the appearance of the
complications associated with the disease, modifying its natural course and prolonging
the life expectancy of patients. Parreira et al.
1919. Parreira SL, Resende MB, Zanoteli E, Carvalho MS, Marie SK, Reed UC.
Comparison of motor strength and function in patients with Duchenne muscular
dystrophy with or without steroid therapy. Arq Neuropsiquiatr. 2010;68(5):683-8.
http://dx.doi.org/10.1590/S0004-282X2010000500002. PMid:21049175
https://doi.org/10.1590/S0004-282X201000...
investigated the relationship between age and
functional capacity in 90 children with DMD aged five to 12 years old treated with
corticoids for approximately seven years. The results did not indicate a significant
relationship between age and functional performance, which the authors explained as due
to steroid treatment, which delayed the progression of DMD. In an international
collaborative study that included 240 individuals with DMD aged two to 28 years old,
Henricson et al.
2020. Henricson EK, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, et al.
The cooperative international neuromuscular research group Duchenne natural history
study: glucocorticoid treatment preserves clinically meaningful functional milestones
and reduces rate of disease progression as measured by manual muscle testing and
other commonly used clinical trial outcome measures. Muscle Nerve. 2013;48(1):55-67.
http://dx.doi.org/10.1002/mus.23808. PMid:23649481
https://doi.org/10.1002/mus.23808...
found that treatment with glucocorticoids
preserved clinically meaningful functional milestones and reduced the rate of disease
progression as measured by manual muscle testing and other commonly used clinical trial
outcome measures, such as pulmonary function tests.
Similar to Parreira et al.1919. Parreira SL, Resende MB, Zanoteli E, Carvalho MS, Marie SK, Reed UC.
Comparison of motor strength and function in patients with Duchenne muscular
dystrophy with or without steroid therapy. Arq Neuropsiquiatr. 2010;68(5):683-8.
http://dx.doi.org/10.1590/S0004-282X2010000500002. PMid:21049175
https://doi.org/10.1590/S0004-282X201000...
, we believe that the
reason that the correlation between age and the functional activity of climbing up and
going down stairs was moderate to weak in our study was that the children were
participating in pharmacological and physical therapy, which may have influenced and
minimized the relationship between age and disease progression. In addition, the fact
that the sample consisted of children only up to eight years old is relevant in this
regard because a larger number of compensatory movements could occur in later stages of
disease.
The results evidenced a relationship between FES-DMD-climbing up and going down stairs
and the VS. We believe that this finding was favored by the considerable involvement of
the lower limbs in the activities tested in the FES-DMD and the VS88. Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive
muscular dystrophy in childhood. JAMA. 1963;184:89-96.
http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
https://doi.org/10.1001/jama.1963.037001...
,
1919. Parreira SL, Resende MB, Zanoteli E, Carvalho MS, Marie SK, Reed UC.
Comparison of motor strength and function in patients with Duchenne muscular
dystrophy with or without steroid therapy. Arq Neuropsiquiatr. 2010;68(5):683-8.
http://dx.doi.org/10.1590/S0004-282X2010000500002. PMid:21049175
https://doi.org/10.1590/S0004-282X201000...
20. Henricson EK, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, et al.
The cooperative international neuromuscular research group Duchenne natural history
study: glucocorticoid treatment preserves clinically meaningful functional milestones
and reduces rate of disease progression as measured by manual muscle testing and
other commonly used clinical trial outcome measures. Muscle Nerve. 2013;48(1):55-67.
http://dx.doi.org/10.1002/mus.23808. PMid:23649481
https://doi.org/10.1002/mus.23808...
-
2121. Sienko Thomas S, Buckon CE, Nicorici A, Bagley A, McDonald CM,
Sussman MD. Classification of the gait patterns of boys with Duchenne muscular
dystrophy and their relationship to function. J Child Neurol. 2010;25(9):1103-9.
http://dx.doi.org/10.1177/0883073810371002. PMid:20587736
https://doi.org/10.1177/0883073810371002...
. Further studies are needed to assess the
relationship between FES-DMD and other scales.
The correlation between VS and FES-DMD-climbing up stairs was strong, while that with
FES-DMD-going down stairs was only moderate. The reason for this difference may be that
VS attributes a particular value to the task climbing up stairs because it is considered
to be a milestone in the progressive degeneration of the functional capacity of
individuals with DMD88. Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive
muscular dystrophy in childhood. JAMA. 1963;184:89-96.
http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
https://doi.org/10.1001/jama.1963.037001...
.
The times spent climbing up and going down the stairs were analyzed and suggested as
parameter of assessment in previous studies by Vignos et al.8 and Brooke et
al.1515. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J,
et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of
supportive therapy. Neurology. 1989;39(4):475-81.
http://dx.doi.org/10.1212/WNL.39.4.475. PMid:2927672
https://doi.org/10.1212/WNL.39.4.475...
. We found that the FES-DMD-climbing up
and going down stairs scores exhibited correlation with the corresponding TA. The time
for climbing up the stairs exhibited a stronger correlation with FES-DMD scores compared
to the time or going down the stairs (r=0.83 versus r=0.40). The reason for this
difference may be the greater motor difficulties involved in climbing up stairs.
Although going down stairs demands considerable control of eccentric muscle contraction
and coordination, the number of compensatory movements was smaller. We observed that,
generally, in the course of going down stairs, the participants tended to accelerate the
forward displacement of the center of mass, for which reason the time of movement in
this task did not differ much between the groups. This compensatory strategy is
compatible with the one reported in the literature2222. Baptista CRJA, Costa AA, Pizzato TM, Souza FB, Mattiello-Sverzut AC.
Postural alignment in children with Duchenne muscular dystrophy and its relationship
with balance. Braz J Phys Ther. 2014;18(2):119-26. PMid:24838810.. One further factor that accounts for this difference is the greater
muscle strength demanded to climb up stairs, which is necessary to support the body's
weight against the action of gravity. Upon going down the stairs, the children held the
handrail for support, thus losing the fear of falling, with consequent reduction of the
time spent on this task.
In the clinical assessment of individuals with DMD, combined use of the TA and the FES-DMD for climbing up and going down stairs is interesting, as although these measures share some components - such as the higher the number of compensatory movements, the longer the time spent in the task - in some cases, the TA may be unchanged as a consequence of an increase in the number of compensatory movements. This finding can only be detected when both assessment tools are used. In such cases, the FES-DMD allowed access to a descriptive characterization of the compensatory movements.
In a similar study, Escorcio et al.1616. Escorcio R, Caromano FA, Hukuda ME, Fernandes LA. Development of an
evaluation scale for sitting and standing from the ground for children with Duchenne
muscular dystrophy. J Mot Behav. 2011;43(1):31-6.
http://dx.doi.org/10.1080/00222895.2010.530306. PMid:21186460
https://doi.org/10.1080/00222895.2010.53...
developed
the scale FES-DMD-sitting and standing from the ground and demonstrated its reliability.
The authors reported a correlation between the scores on the FES-DMD-sitting and
standing from the ground and age, VS and TA. Upon investigating the relationship between
the FES-DMD scores and age, they found a weak correlation between FES-DMD-sitting on the
ground and age but no correlation between FES-DMD-standing from the ground and age. The
FES-DMD-sitting on the ground score exhibited a weak correlation with VS (r=0.21), while
the FES-DMD-standing from the ground score exhibited a moderate correlation with VS
(r=0.56). FES-DMD-sitting on the ground did not have a significant correlation with TA,
while the correlation between FES-DMD-standing from the ground and TA was strong
(r=0.79). These results are similar to those of the present study, i.e., the
correlations between variables were stronger for activities that demanded greater
strength and neuromuscular control (i.e., climbing up stairs and standing from the
ground).
Hukuda et al.1717. Hukuda ME, Escorcio R, Fernandes LA, de Carvalho EV, Caromano FA.
Evaluation scale development, reliability for sitting and standing from the chair for
Duchenne muscular dystrophy. J Mot Behav. 2013;45(2):117-26.
http://dx.doi.org/10.1080/00222895.2012.760513. PMid:23488586
https://doi.org/10.1080/00222895.2012.76...
developed and demonstrated the
reliability of the FES-DMD-sitting and standing from a chair. Only the FES-DMD-sitting
on the chair score exhibited moderate correlation with age (r=0.44). They also reported
moderate correlations between FES-DMD-sitting and standing from a chair with TA and VS
(r=0.69 and r=0.66, respectively). VS exhibited few elements in common with the
activities sitting and standing from a chair, in contrast to the tasks investigated in
the present study, which were also tested in the VS.
Our findings call attention to two facts. The variable age was not adequate when used alone to describe the functional progression of individuals with DMD because it did not reflect the functional alterations that might be observed such tasks as climbing up and going down stairs, which was evidenced by the poor correlation between age and the FES-DMD scores.
In contrast, VS, which is the precursor of the functional scales for assessment of individuals with DMD, showed a strong correlation with FES-DMD-climbing up stairs and a moderate correlation with FES-DMD-going down stairs. Therefore, these two tools could be used in a complementary manner, allowing not only classification but also an understanding of the mechanisms underlying compensatory movements, especially those used to go down stairs.
We believe that the time spent in the performance of the tasks should also be taken into consideration, which was already incorporated into the FES-DMD, as an increase in the number of compensatory movements while climbing up stairs implies a longer time spent in the execution of the task, whereas the time needed to go down the stairs may decrease as a function of abrupt displacements favored by gravity. As we expected, the FES-DMD-climbing up stairs exhibited a strong correlation with the time needed to perform the task.
Our sample showed the relationships existing between the investigated variables relative to children up to approximately eight years old. We believe that future studies could show these relationships in greater detail in groups of patients with different age ranges.
Conclusion
We conclude that FES-DMD-climbing up stairs bears a moderate correlation with age and strong correlations with VS and the time needed to perform this specific activity. The correlations between FES-DMD-going down stairs and age, VS and the specific TA were weak in children with DMD.
These findings indicate that assessment of the task of climbing up stairs may produce more precise information on the progression of DMD, although the task of going down stairs should also be assessed, with the goal of establishing guidance and accident prevention.
Joint use of the FES-DMD data, age and TA is recommended when making decisions regarding functional diagnoses. Longitudinal studies that include samples with wider age ranges may complement this information.
The Mayana Zatz, and Mariz Vainzof, for the permission to use the images database (films) of the Laboratory of Myopathies of Institute of Biosciences of University of São Paulo.
References
-
1McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil. 2002;81(11, Suppl):S108-20. http://dx.doi.org/10.1097/00002060-200211001-00012. PMid:12409816
» https://doi.org/10.1097/00002060-200211001-00012 -
2Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J. The multidisciplinary management of Duchenne muscular Dystrophy. Curr Paediatr. 2005;15(4):292-300. http://dx.doi.org/10.1016/j.cupe.2005.04.001.
» https://doi.org/10.1016/j.cupe.2005.04.001 -
3Ambrosino N, Carpenè N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J. 2009;34(2):444-51. http://dx.doi.org/10.1183/09031936.00182208. PMid:19648521
» https://doi.org/10.1183/09031936.00182208 -
4Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177-89. http://dx.doi.org/10.1016/S1474-4422(09)70272-8. PMid:19945914
» https://doi.org/10.1016/S1474-4422(09)70272-8 -
5Zanoteli E. Predicting the loss of ambulation in Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2014;72(1):1-2. http://dx.doi.org/10.1590/0004-282X20130243. PMid:24637971
» https://doi.org/10.1590/0004-282X20130243 -
6Silva EC, Machado DL, Resende MB, Silva RF, Zanoteli E, Reed UC. Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2012;70(3):191-5. PMid:22392111.
-
7Scott E, Mawson SJ. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. Dev Med Child Neurol. 2006;48(6):540-4. http://dx.doi.org/10.1017/S0012162206001137. PMid:16700951
» https://doi.org/10.1017/S0012162206001137 -
8Vignos PJ Jr, Spencer GE Jr, Archibald KC. Management of progressive muscular dystrophy in childhood. JAMA. 1963;184:89-96. http://dx.doi.org/10.1001/jama.1963.03700150043007. PMid:13997180
» https://doi.org/10.1001/jama.1963.03700150043007 -
9Bérard C, Payan C, Hodgkinson I, Fermanian J, MFM Collaborative Study Group. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7):463-70. http://dx.doi.org/10.1016/j.nmd.2005.03.004. PMid:16106528
» https://doi.org/10.1016/j.nmd.2005.03.004 -
10Vuillerot C, Payan C, Girardot F, Fermanian J, Iwaz J, Bérard C, et al. Responsiveness of the motor function measure in neuromuscular diseases. Arch Phys Med Rehabil. 2012;93(12):2251-6.e1. http://dx.doi.org/10.1016/j.apmr.2012.05.025. PMid:22705238
» https://doi.org/10.1016/j.apmr.2012.05.025 -
11de Lattre C, Payan C, Vuillerot C, Rippert P, de Castro D, Bérard C, et al. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil. 2013;94(11):2218-26. http://dx.doi.org/10.1016/j.apmr.2013.04.001. PMid:23602884
» https://doi.org/10.1016/j.apmr.2013.04.001 -
12Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, et al. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int. 2012;17(2):101-9. http://dx.doi.org/10.1002/pri.520. PMid:21954141
» https://doi.org/10.1002/pri.520 -
13Mazzone E, Martinelli D, Berardinelli A, Messina S, D'Amico A, Vasco G, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2010;20(11):712-6. http://dx.doi.org/10.1016/j.nmd.2010.06.014. PMid:20634072
» https://doi.org/10.1016/j.nmd.2010.06.014 -
14Fernandes LA, Caromano FA, Hukuda ME, Escorcio R, Carvalho EV. Elaboration and reliability of functional evaluation on going up and downstairs scale for Duchenne Muscular Dystrophy. Rev Bras Fisioter. 2010;14(6):518-26. http://dx.doi.org/10.1590/S1413-35552010000600011. PMid:21340247
» https://doi.org/10.1590/S1413-35552010000600011 -
15Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39(4):475-81. http://dx.doi.org/10.1212/WNL.39.4.475. PMid:2927672
» https://doi.org/10.1212/WNL.39.4.475 -
16Escorcio R, Caromano FA, Hukuda ME, Fernandes LA. Development of an evaluation scale for sitting and standing from the ground for children with Duchenne muscular dystrophy. J Mot Behav. 2011;43(1):31-6. http://dx.doi.org/10.1080/00222895.2010.530306. PMid:21186460
» https://doi.org/10.1080/00222895.2010.530306 -
17Hukuda ME, Escorcio R, Fernandes LA, de Carvalho EV, Caromano FA. Evaluation scale development, reliability for sitting and standing from the chair for Duchenne muscular dystrophy. J Mot Behav. 2013;45(2):117-26. http://dx.doi.org/10.1080/00222895.2012.760513. PMid:23488586
» https://doi.org/10.1080/00222895.2012.760513 -
18Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, et al. The correlation analysis of functional factors and age with duchenne muscular dystrophy. Ann Rehabil Med. 2012;36(1):22-32. http://dx.doi.org/10.5535/arm.2012.36.1.22. PMid:22506232
» https://doi.org/10.5535/arm.2012.36.1.22 -
19Parreira SL, Resende MB, Zanoteli E, Carvalho MS, Marie SK, Reed UC. Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy. Arq Neuropsiquiatr. 2010;68(5):683-8. http://dx.doi.org/10.1590/S0004-282X2010000500002. PMid:21049175
» https://doi.org/10.1590/S0004-282X2010000500002 -
20Henricson EK, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, et al. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle Nerve. 2013;48(1):55-67. http://dx.doi.org/10.1002/mus.23808. PMid:23649481
» https://doi.org/10.1002/mus.23808 -
21Sienko Thomas S, Buckon CE, Nicorici A, Bagley A, McDonald CM, Sussman MD. Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function. J Child Neurol. 2010;25(9):1103-9. http://dx.doi.org/10.1177/0883073810371002. PMid:20587736
» https://doi.org/10.1177/0883073810371002 -
22Baptista CRJA, Costa AA, Pizzato TM, Souza FB, Mattiello-Sverzut AC. Postural alignment in children with Duchenne muscular dystrophy and its relationship with balance. Braz J Phys Ther. 2014;18(2):119-26. PMid:24838810.
Publication Dates
-
Publication in this collection
Nov-Dec 2014
History
-
Received
06 June 2013 -
Reviewed
13 Jan 2014 -
Accepted
07 July 2014